COCs containing 35 μg EE and 2 mg CPA were shown to significantly increase sCD40L from 1.33 ng/ml to 2.7 ng/ml (ES = 1.37; p = 0.011) after three months of use in PCOS subjects [40]. Here, CD40LG is linked to polycystic ovary syndrome.